| abstract |
This invention relates to heterocyclic ketones of formula (I) wherein R is C1-C6 alkyl, C1-C6 alkoxy, F, Br, Cl, and I; Ar<1> is phenyl, naphthyl or thiophene; Ar<2> is phenyl or pyridyl; X is C, N or S; I is 0 through 9; m is 2 through 7; n is 0, 1 or 2; p is 0, 1 or 2; and pharmaceutically acceptable salts thereof, useful in treating NPY Y5 receptor mediated conditions, and to novel intermediates and improved processes relating thereto. |